The objective of this study is to compare serum and urine reactive nitrogen intermediates (RNI) and citrulline levels in children with Henoch-Schonlein purpura (HSP) during activity and remission. The study group consisted of 14 children with HSP. We measured serum and urine RNI and citrulline levels by spectrophotometry in the active phase of the disease and then during remission. Serum RNI levels were 303.95 § 221.44 nmol/ml in children with active HSP and 72.57 § 26.56 nmol/ml during remission, the diVerences being statistically signiWcant (P = 0.002). Mean urine RNI levels in children with active HSP were signiWcantly higher than that seen during remission (3.25 § 1.80 vs. 1.68 § 0.65 nmol/ml; P = 0.003). Similarly, serum citrulline levels during disease activity were 790.65 § 707.87 nmol/ml as compared to 281.49 § 307.29 nmol/ml at the time of remission, the diVerences being statistically signiWcant (P = 0.002). Mean urine citrulline levels in children with active disease was 1,969.94 § 1655.42 nmol/ml as compared to 1,099.34 § 955.82 nmol/ml in children with remission, (P = 0.007). Serum and urine RNI and citrulline levels were signiWcantly higher during the acute phase of HSP as compared to the levels obtained during the phase of disease remission. These Wndings suggest that nitric oxide may perhaps have a role in the pathogenesis of HSP. Further, these laboratory parameters could be of value in monitoring disease activity. To the best of our knowledge, this study is the most comprehensive work published on the subject so far. Our Wndings, however, need to be conWrmed on a larger study sample before Wrm conclusions can be drawn.
Introduction
Henoch-Schonlein purpura (HSP) is the commonest systemic vasculitic disorder of childhood with an incidence of 13.5 cases per 100,000 children [1] [2] [3] . It is an immunecomplex-mediated disease characterized by circulating immune complexes containing immunoglobulin A (IgA) predominantly in dermal, intestinal and glomerular capillaries [4] . It has been reported that cytokine-mediated neutrophil dependent injury to endothelial cells is an important event in the pathogenesis of diVerent forms of vasculitides and this endothelial injury may be associated with stimulated nitric oxide (NO) production [5] [6] [7] [8] . Cytokine exposure has been demonstrated to induce NO pathway both in vitro and in vivo [9] . This indicates the role for the L-arginine/NO-synthase pathway [9] in the cytotoxicity following cytokine activation. The role of NO as second messenger has been well worked out in various inXammatory diseases [5] [6] [7] [8] .
Nitric oxide, being unstable, is readily broken down into nitrate and nitrite. Detection of NO by direct measures is technically diYcult. Nitrites and nitrates are stable end products of NO metabolism and they were measured in serum and urine as RNI. NO is synthesized from one of the terminal nitrogen atoms of L-arginine, catalyzed by several NO synthases [9] , which generate NO and citrulline. RNI and citrulline are, therefore, used as surrogate indices of increased activity of nitric oxide synthase [10, 11] .
Despite the pathophysiological importance of NO in endothelial cell damage, not enough is known about the role of NO pathway in HSP. The present study is an attempt to Wll up some of these lacunae in the literature.
Patients and methods
The study was conducted between November 2003 and December 2004 on 14 patients diagnosed to have HSP and registered in the Pediatric Rheumatology and Immunology Clinic of the Department of Pediatrics, Advanced Pediatric Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India. The diagnosis of HSP was made if a child fulWlled the following criteria: non-thrombocytopenic palpable purpura on extensor aspects of legs or on buttocks with demonstration of either leukocytoclostic vasculitis on skin biopsy or immunoglobulin A deposits on immunoXuorescence [1] . Children receiving corticosteroids or cytotoxic drugs, and those with urinary tract or systemic infections were excluded.
A child was said to be in remission when the rash had disappeared, there was no arthritis or gastrointestinal complaints, and the urine examination was normal.
Venous blood was collected after an overnight fast at the time of enrolment during the acute phase of the illness and subsequently during remission at the time of Wrst follow-up visit approximately 4 weeks later. Serum was separated by centrifugation and aliquots were stored at ¡20°C till Wnal analysis. Urine samples were obtained in early morning in order to minimize the eVect of dietary intake of arginine. Urine was also stored at ¡20°C.
All biochemical estimations were carried out in the Department of Experimental Medicine and Biotechnology under the direct supervision of M.K.
Reactive nitrogen intermediates were measured by the method of Green et al. [12] ; 100 l of sample was diluted with 400 l of distilled water and made to react with 500 l of Griess reagent. This solution was incubated for 10 min at 37°C. Absorbance at 546 nm was measured using Uvikon spectrophotometer and nitric oxide concentration was calculated from a sodium nitrate standard concentration.
For serum citrulline estimation [13] , 100 l of serum was diluted 20-fold and then deproteinated using 0.5 ml of 25% tricarboxylic acid solution. A quantity of 1.5 ml of chromogenic solution was then added to 0.5 ml of clear supernatant obtained from deproteinated serum. This was mixed vigorously and boiled at 100°C for 5 min. The tubes were then cooled and absorbance read at 530 nm. DL-citrulline (25-300 nmol) was used as a standard.
The Institute Ethics Committee approved the study protocol.
Statistical Analysis
Results were expressed as mean § SD. Comparison between active and remission phase was made using paired t test. A P value of ·0.05 was considered statistically sig-niWcant.
Results
Cutaneous palpable purpuric rash was the presenting complaint in all the patients (Table 1 ). Lower limb involvement was universal; in addition, there was upper limb involvement in four cases (28.6%). Buttocks were involved in eight patients (57.1%). Average duration of the rash was 17.64 days (range 7-29 days). Three patients (21.4%) had one or more recurrences of rash. The recurrences occurred over 12-40 days after the resolution of initial symptoms. Arthritis was noted in seven patients and always followed the rash. Knee joint was most commonly involved and was the Wrst joint to be aVected in 85.7% of patients. Mean duration of arthritis was 7.86 days (range 2-20 days). Nausea and vomiting was the commonest (64.3%) gastrointestinal complaint. Seven patients (50%) had periumbilical pain. Gastrointestinal bleeding was present in Wve patients (35.7%). It was occult in two patients and overt in three patients ( Table 1) . None of these patients developed an intussusception. Renal involvement was seen in four patients (28.6%). Mean age of patients with renal involvement was 6 years (range 3-11 years). All four patients had signiWcant proteinuria (>4 mg/m 2 per hour) while two had hematuria; this was microscopic in one and gross in the other. None of these patients had renal insuYciency or evidence of residual renal disease during follow-up. Mean Serum and urine RNI and citrulline levels during disease activity and remission are given in Table 2 , while the levels in individual patients are given in Figs. 1, 2, 3 and 4 .
Our results show that mean serum and urine RNI levels in children with active HSP were signiWcantly higher than those seen in remission (P < 0.05). Similarly, mean serum and urine citrulline levels in children with active HSP were higher when compared with those in remission, the diVerence being statistically signiWcant (P < 0.05).
Mean serum RNI in the four patients with renal involvement (n = 4) appeared to be higher than in the ten patients with no renal involvement (555.13 § 251.23 vs. 203.48 § 102.65 nmol/ml; P = 0.002). There was, however, no diVerence in mean urine RNI levels between the two groups. Similarly, there was no diVerence in the mean serum and urine citrulline levels between patients with and without renal involvement (P > 0.05).
Discussion
HSP is an immune-complex-mediated disease characterized by presence of polymeric IgA1 (pIgA1)-containing immune complexes predominantly in dermal, gastrointestinal, and glomerular capillaries [1] [2] [3] [4] . Various mediators of inXammation (e.g., cytokines, free oxygen radicals, leukotrienes) have been implicated in the pathogenesis of HSP, but exact etiology remains an enigma.
Nitric oxide has been hypothesized to play a role in various rheumatological disorders (e.g., systemic lupus erythematosus [10] , juvenile rheumatoid arthritis [11] ) and in several vasculitides including Kawasaki disease [14] ). However, there is paucity of literature in the role of NO in HSP.
In this study, we enrolled 14 children who were diagnosed to have HSP on clinical grounds. This clinical diagnosis was further conWrmed by histopathological examination and immunoXuorescence studies performed on the skin biopsy. It may be noted that the rash of HSP is not always pathognomonic and the cutaneous lesions may, at times, mimic other rheumatological and non-rheumatological disorders [15, 16] , especially in the initial phase of the illness. In our experience, a skin biopsy is often helpful in such situations. Previous workers on the subject [6] [7] [8] have not commented on the role of skin biopsy in their studies.
We chose not to include any matched normal controls in this study, because of ethical considerations with regard to blood sampling in children. However, the study patients themselves served as their individual controls when they were sampled during the phase of disease remission.
Nitric oxide is synthesized from one of the terminal nitrogen atoms of L-arginine, catalyzed by several NO synthases [9] which generate NO and citrulline. Being unstable, NO is readily broken down into nitrate and nitrite. NO can be measured by chemiluminescence reaction, diazotization of sulfanilic acid assay, electron paramagnetic resonance and spectrophotometry [11] . The Wrst three methods are technically diYcult. RNI and citrulline are considered to be surrogate markers of NO synthase [10, 11] . Analysis of RNI and citrulline by spectrophotometry is a reliable method of assessment of NO activity and has been used previously in patients with systemic lupus erythematosus, rheumatoid arthritis and juvenile rheumatoid arthritis 10, 11] . It has been recently reported that, of the two, citrulline levels may, in fact, be a better modality for assessment of NO synthase activity as compared to RNI in diseases like rheumatoid arthritis and systemic lupus erythematosus [10] . Previous workers on the subject [6] [7] [8] have not measured serum and urine citrulline levels in HSP. The present study has Wlled up this important lacuna in the literature.
We have demonstrated that mean levels of both RNI and citrulline in serum and urine are signiWcantly higher during active HSP as compared to remission. Our results are in concordance with the previous studies on the subject [6] [7] [8] . However, as has been mentioned already, none of the previous workers have commented on the role of citrulline.
We did not explore the cellular source of increased NO production. It may be secondary to cytokine-mediated endothelial injury [5, 17] . Cytokine exposure has been demonstrated to induce the NO pathway in vitro as well as in vivo [5] . Although our study suggests a possible correlation between levels of serum and urine NO and the acute of the disease of HSP, genetic analysis of inducible NO synthase polymorphism has yielded variable results. While Martin et al. [18] have shown that inducible NO synthase polymorphism is associated with susceptibility to HSP, Amoli et al. [19] have not been able to conWrm this Wnding.
To conclude, therefore, our study has shown that serum and urine RNI and citrulline levels were signiWcantly higher during the active phase of HSP as compared to the levels obtained during the phase of disease remission. This study is the most comprehensive work published on the subject so far. Our Wndings suggest that nitric oxide may perhaps have a role in the pathogenesis of HSP. Further, these laboratory parameters could be of value in monitoring disease activity. Our results, however, need to be conWrmed on a larger study sample before Wrm conclusions can be drawn. Modulation of NO synthesis may also perhaps represent a new approach to the treatment of this condition.
